RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 111 filers reported holding RAPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,571,986 | -11.1% | 94,584 | +0.0% | 0.00% | – |
| Q2 2023 | $1,768,365 | +3.7% | 94,565 | +1.7% | 0.00% | – |
| Q1 2023 | $1,705,486 | +4.5% | 92,942 | +12.8% | 0.00% | – |
| Q4 2022 | $1,631,976 | -15.9% | 82,423 | +2.2% | 0.00% | – |
| Q3 2022 | $1,941,000 | +47.8% | 80,652 | +12.1% | 0.00% | – |
| Q2 2022 | $1,313,000 | -9.3% | 71,967 | +9.4% | 0.00% | – |
| Q1 2022 | $1,447,000 | -40.3% | 65,787 | -0.3% | 0.00% | – |
| Q4 2021 | $2,423,000 | -7.9% | 65,971 | -22.1% | 0.00% | -100.0% |
| Q3 2021 | $2,631,000 | +16.5% | 84,727 | +19.2% | 0.00% | – |
| Q2 2021 | $2,259,000 | +120.2% | 71,085 | +53.8% | 0.00% | – |
| Q1 2021 | $1,026,000 | +10.9% | 46,207 | -1.2% | 0.00% | – |
| Q4 2020 | $925,000 | -3.4% | 46,776 | +57.2% | 0.00% | – |
| Q3 2020 | $958,000 | +12.0% | 29,749 | +0.8% | 0.00% | – |
| Q2 2020 | $855,000 | – | 29,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |